Clinical Trial: Clinical Trial of Avasopasem in Patients With Metastatic Hormone Receptor Positive Breast Cancer With Progression on a CDK 4/6 Inhibitor and Hormonal Therapy

U.S., Aug. 23 -- ClinicalTrials.gov registry received information related to the study (NCT07137871) titled 'Clinical Trial of Avasopasem in Patients With Metastatic Hormone Receptor Positive Breast Cancer With Progression on a CDK 4/6 Inhibitor and Hormonal Therapy' on Aug. 15.

Brief Summary: This study aims to evaluate the safety of avasopasem in combination with CDK 4/6 inhibitor and hormonal therapy in women with metastatic hormone receptor positive breast cancer, and to see if the addition of avasopasem improves the effectiveness of a CDK 4/6 inhibitor and hormonal therapy.

Study Start Date: Sept., 2025

Study Type: INTERVENTIONAL

Condition: Breast Cancer Metastatic

Intervention: DRUG: Avasopasem

Avasopasem has also been shown t...